Entry
Name
Inavolisib (USAN/INN); Itovebi (TN)
Product
Formula
C18H19F2N5O4
Exact mass
407.1405
Mol weight
407.37
Structure
Mol file KCF file DB search
Class
Antineoplastic
DG03139 PI3K inhibitor
Remark
Efficacy
Antineoplastic, Phosphatidylinositol 3-kinase inhibitor
Disease
Breast cancer (endocrine-resistant, PIK3CA-mutated, HR positive, HER2 negative) [DS:
H00031 ]
Target
Pathway
hsa04662 B cell receptor signaling pathway
Brite
Drug groups [BR:br08330 ]
Antineoplastic
DG03139 PI3K inhibitor
D11942 Inavolisib
Target-based classification of drugs [BR:br08310 ]
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3CA
D11942 Inavolisib (USAN/INN) <US>
New drug approvals in the USA [br08319.html ]
New molecular entities and new therapeutic biological products
D11942
New drug approvals in the USA, Europe and Japan [br08328.html ]
Approval dates by FDA, EMA and PMDA
D11942
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 29
1 C8x C 16.6600 -17.0800
2 C8y C 16.6600 -18.4800
3 C8x C 17.9200 -19.1800
4 C8y C 19.1800 -18.4800
5 C8y C 19.1800 -17.0800
6 C8x C 17.9200 -16.3800
7 C8y C 20.3000 -16.1700
8 N4y N 21.6300 -16.5200
9 C1x C 22.3300 -17.7800
10 C1x C 21.6300 -19.0400
11 O2x O 20.3000 -19.3200
12 N1b N 15.4700 -19.1800
13 C8x C 22.4700 -15.3300
14 C8y C 21.4900 -14.2800
15 N5x N 20.2300 -14.7700
16 N1y N 21.9100 -12.8800
17 C7x C 23.2400 -12.3900
18 O7x O 23.1700 -10.9900
19 C1x C 21.8400 -10.6400
20 C1y C 21.0000 -11.8300
21 O6a O 24.4300 -13.1600
22 C1c C 19.6000 -11.9000
23 X F 18.8300 -10.7100
24 X F 18.9700 -13.1600
25 C1c C 14.2800 -18.4800
26 C5a C 13.0900 -19.1800
27 C1a C 14.2800 -17.0800
28 N1a N 11.9000 -18.4800
29 O5a O 13.0900 -20.5800
BOND 32
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 8 9 1
8 9 10 1
9 7 8 1
10 4 11 1
11 5 7 1
12 10 11 1
13 2 12 1
14 8 13 1
15 13 14 2
16 14 15 1
17 7 15 2
18 14 16 1
19 16 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 17 21 2
24 20 16 1
25 20 22 1 #Down
26 22 23 1
27 22 24 1
28 12 25 1
29 25 26 1
30 25 27 1 #Down
31 26 28 1
32 26 29 2